Cargando…
Platelet-derived growth factor in glioblastoma—driver or biomarker?
TP53: The platelet-derived growth factor (PDGF) family of mitogens exerts vital functions during embryonal development, e.g. in the central nervous system, where PDGF drives the proliferation of oligodendrocyte precursors. PDGF and PDGF receptors are co-expressed in human glioblastoma (GBM). Whether...
Autor principal: | Westermark, Bengt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248069/ https://www.ncbi.nlm.nih.gov/pubmed/25342206 http://dx.doi.org/10.3109/03009734.2014.970304 |
Ejemplares similares
-
Glioblastoma—a moving target
por: Westermark, Bengt
Publicado: (2012) -
Structural and functional aspects of platelet-derived growth factor.
por: Heldin, C. H., et al.
Publicado: (1988) -
Differential expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human lung carcinoma cell lines.
por: Heldin, N. E., et al.
Publicado: (1993) -
Platelet-derived growth factor (PDGF) in neoplastic and non-neoplastic cystic lesions of the central nervous system and in the cerebrospinal fluid.
por: Nistér, M., et al.
Publicado: (1994) -
Prognostic implications of epidermal and platelet-derived growth factor receptor alterations in 2 cohorts of IDHwt glioblastoma
por: Alnahhas, Iyad, et al.
Publicado: (2021)